Therefore, the lethality of PAK3 or SGK2 shRNAs to HPV+ cervical cancer cells did not appear related to the inhibition of PAK3 or SGK2 expression but rather through a non-specific RNAi effect. The gene discussed is SGK2; the disease is cervical cancer.